Celldex Therapeutics Inc
NASDAQ:CLDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
E
|
Eco&Dream Co Ltd
KOSDAQ:101360
|
KR |
|
First Capital Inc
NASDAQ:FCAP
|
US |
|
D
|
Dynapack International Technology Corp
TPEX:3211
|
TW |
|
A
|
Al-Abbas Sugar Mills Ltd
KAR:AABS
|
PK |
|
Immunovant Inc
NASDAQ:IMVT
|
US |
|
FirstGroup PLC
LSE:FGP
|
UK |
|
B
|
BTL Inc
TPEX:6840
|
TW |
|
S
|
SSH Communications Security Oyj
OMXH:SSH1V
|
FI |
|
P
|
Pivotree Inc
OTC:PVTRF
|
CA |
|
A
|
Apex Material Technology Corp
TPEX:6899
|
TW |
|
B
|
Bain Capital Specialty Finance Inc
F:618
|
US |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
|
Q
|
QuantaMatrix Inc
KOSDAQ:317690
|
KR |
|
Asahi Co Ltd
OTC:AAHIF
|
JP |
|
V
|
Verbio SE
DUS:VBK
|
DE |
|
Shikoku Electric Power Co Inc
OTC:SHEKF
|
JP |
|
Cartesian Growth Corp III
NASDAQ:FAC
|
US |
|
A
|
Abbott Laboratories Pakistan Ltd
KAR:ABOT
|
PK |
|
Capral Ltd
F:CBZ
|
AU |
|
transcosmos Inc
TSE:9715
|
JP |
|
T
|
Trans-Sun Materials Technology Co Ltd
TPEX:6967
|
TW |
|
E
|
Etablissements Maurel et Prom SA
F:ETX
|
FR |
|
Impack Pratama Industri Tbk PT
IDX:IMPC
|
ID |
Bankruptcy Probability
Celldex Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celldex Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
2.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celldex Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celldex Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.